Going great, but main issue will be the patent protection. If they don't get a tight patent protection pretty quickly, I assume the market will be flooded with competitors.
Neither the drug nor the delivery system can be patent protected, just the specific approach to making it into a nasal formulation.
Revenue - what does it look like?, page-68
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
-0.040(3.20%) |
Mkt cap ! $102.5M | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.28 | $1.18 | $682.7K | 564.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 155 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 815 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| LTP (ASX) Chart |